MOTS-C-MAX-10
Mitochondrial Peptide|10 mg × 10 Vials
An experimental research peptide product containing MOTS-c, a mitochondria-derived peptide investigated in cellular, metabolic, and preclinical research.
Each vial contains 10 mg, with 10 vials per kit, providing a total labeled quantity of 100 mg. Designed for qualified laboratory and research applications, MOTS-C-MAX-10 provides researchers with a clearly identified peptide format suitable for controlled experimental workflows.
Product Highlights
About MOTS-c
MOTS-c is a mitochondria-derived peptide that has been investigated in experimental research because of its association with cellular and metabolic processes.
Researchers have studied MOTS-c in cellular, biochemical, and preclinical models, investigating areas such as metabolic signaling, mitochondrial biology, cellular stress responses, and energy-related pathways.
MOTS-c research continues to explore its biological characteristics and potential mechanisms of action within controlled experimental systems.
However, findings from laboratory and animal studies should not be interpreted as established evidence of safety or efficacy in humans.
MOTS-C-MAX-10 is therefore presented as an experimental research compound, rather than an approved therapeutic product.
Product Specifications
| PRODUCT NAME | MOTS-C-MAX-10 |
| COMPOUND | MOTS-c |
| PRODUCT TYPE | Mitochondrial Peptide |
| QUANTITY PER VIAL | 10 mg |
| NUMBER OF VIALS | 10 |
| TOTAL QUANTITY | 100 mg |
| PRODUCT CATEGORY | Research Peptide |
| PHYSICAL FORM | Lyophilized* |
| INTENDED APPLICATION | Laboratory / Research Use |
| PACKAGING | 10-vial kit |
| BRAND | Maxtreme Pharma |
*Confirm the physical form against the manufacturer's current technical documentation before publishing.
Research Applications
MOTS-c has been investigated in experimental research involving mitochondrial biology, cellular metabolism, and metabolic signaling. Research areas may include:
Researchers may investigate MOTS-c within controlled experimental models to better understand its biological activity and relationship with cellular pathways.
These research areas describe experimental investigation only and do not constitute approved medical indications or recommendations for human use.
MOTS-c Research Profile
MOTS-c is a mitochondria-derived peptide associated with research into the relationship between mitochondrial activity and cellular metabolic processes.
Experimental studies have examined its involvement in biological pathways associated with cellular metabolism, energy regulation, and stress responses.
Research into MOTS-c remains an evolving area, and results obtained from cellular or animal models should not automatically be extrapolated to therapeutic outcomes in humans.
Researchers should consult relevant scientific literature and the product-specific technical documentation when evaluating MOTS-c for laboratory applications.
Quality & Packaging
The MOTS-C-MAX-10 kit contains 10 individually packaged vials, with 10 mg of labeled peptide per vial, providing a total labeled quantity of 100 mg per kit.
The packaging clearly identifies the product as a Mitochondrial Peptide and specifies both the individual vial strength and overall kit quantity.
For professional research procurement, researchers should verify the applicable Certificate of Analysis (CoA), batch/lot number, peptide identity, purity specifications, testing information, and storage requirements associated with the specific batch.
Storage & Handling
Store and handle MOTS-C-MAX-10 according to the manufacturer's batch-specific technical documentation and Certificate of Analysis.
Peptide stability may be affected by factors including temperature, moisture, light exposure, formulation, and handling conditions.
Researchers should follow the manufacturer's documented storage and handling requirements rather than relying on generic storage recommendations.
Appropriate laboratory procedures and applicable safety protocols should be followed when handling experimental peptide materials.
MOTS-C-MAX-10 is an experimental research peptide and is not presented as a drug, dietary supplement, or approved treatment for any medical condition.
This product is intended for qualified research and laboratory applications in accordance with applicable laws, regulations, institutional requirements, and laboratory safety procedures.
No claim is made that MOTS-c is safe or effective for the diagnosis, treatment, cure, or prevention of any disease or medical condition.
Not for human consumption or self-administration.
Frequently Asked Questions
MOTS-C-MAX-10 is an experimental research peptide product containing MOTS-c, a mitochondria-derived peptide investigated in cellular, metabolic, and preclinical research.
Each vial contains 10 mg of MOTS-c according to the product packaging.
The kit contains 10 vials.
The kit contains 100 mg total, calculated as 10 vials × 10 mg per vial.
MOTS-c is a mitochondria-derived peptide that has been investigated experimentally in areas involving mitochondrial biology, cellular metabolism, and metabolic signaling.
MOTS-c has been investigated in experimental research involving mitochondrial function, cellular energy metabolism, metabolic signaling, and cellular stress responses. These research areas should not be interpreted as established medical applications.
MOTS-c should not be presented as an approved human therapeutic. It is an experimental research peptide, and preclinical findings do not establish therapeutic safety or efficacy in humans.
No. The product should be presented as For Research Use Only and not for human consumption or self-administration, subject to applicable laws and regulatory requirements.
For professional research procurement, customers should request the applicable Certificate of Analysis (CoA) and batch information. Depending on research requirements, documentation may include information relating to peptide identity, purity, testing, and storage conditions.